Extracellular signal-regulated kinases 1 and 2 participate in interleukin-17 plus tumor necrosis factor-α-induced stabilization of interleukin-6 mRNA in human pancreatic myofibroblasts
- 19 August 2002
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1591 (1-3) , 69-74
- https://doi.org/10.1016/s0167-4889(02)00250-1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (12470121, 13470119)
This publication has 28 references indexed in Scilit:
- Combinations of ERK and p38 MAPK Inhibitors Ablate Tumor Necrosis Factor-α (TNF-α) mRNA InductionJournal of Biological Chemistry, 2001
- Regulation of tumour necrosis factor α mRNA stability by the mitogen‐activated protein kinase p38 signalling cascadeFEBS Letters, 2000
- Interleukin-17 is Produced by Both Th1 and Th2 Lymphocytes, and Modulates Interferon-γ- and Interleukin-4-Induced Activation of Human KeratinocytesJournal of Investigative Dermatology, 2000
- SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin‐1Published by Wiley ,2000
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- How MAP Kinases Are RegulatedJournal of Biological Chemistry, 1995
- Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27Cell, 1994
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domainPublished by Elsevier ,1994
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994